608
Participants
Start Date
June 18, 2021
Primary Completion Date
June 1, 2027
Study Completion Date
June 1, 2027
Randomised treatment advice (discontinue vs continue after 3 months)
Randomisation to continue or discontinue anticoagulant therapy in 1:1 ratio stratified on risk category of L-TRRiP and VTE-BLEED score
VTE-BLEED score
Predict bleeding risk during extended anticoagulant treatment (high or low) using the VTE-BLEED score
L-TRRiP score
Predict VTE recurrence risk after anticoagulant discontinuation (high, intermediate or low) using the L-TRRiP score
Advise to continue anticoagulant treatment after 3 months
Advise to continue anticoagulant treatment after 3 months for patients with high VTE recurrence and low bleeding risk
Advise to discontinue anticoagulant treatment after 3 months
Advise to discontinue anticoagulant treatment after 3 months for patients with low VTE recurrence risk
RECRUITING
Leiden University Medical Center, Leiden
RECRUITING
Amsterdam Medical Center, location AMC, Amsterdam
RECRUITING
Wilhelmina Ziekenhuis, Assen
RECRUITING
Rode Kruis Ziekenhuis, Beverwijk
RECRUITING
Amphia Ziekenhuis, Breda
RECRUITING
Deventer Ziekenhuis, Deventer
RECRUITING
Nij Smellinghe Ziekenhuis, Drachten
RECRUITING
Ziekenhuis Gelderse Vallei, Ede
RECRUITING
Catharina Ziekenhuis, Eindhoven
RECRUITING
Admiraal de Ruyter Ziekenhuis, Goes
RECRUITING
Groene Hart Ziekenhuis, Gouda
RECRUITING
Martini Ziekenhuis, Groningen
RECRUITING
University Medical Center Groningen, Groningen
RECRUITING
Radboud University Medical Center, Nijmegen
RECRUITING
Ikazia Ziekenhuis, Rotterdam
RECRUITING
Haaglanden Medisch Centrum, The Hague
RECRUITING
HagaZiekenhuis, The Hague
RECRUITING
Diakonessenhuis, Utrecht
RECRUITING
Isala Klinieken, Zwolle
Leiden University Medical Center
OTHER